Article
Insights into pharmacogenomics and its impact upon immunosuppressive therapy.
Transplant immunology - 1 May 2002
Yagil Yoram, Yagil Chana
Abstract excerpt
The advent of the genomic era has brought about several new fields of study, one of them being pharmacogenomics, which seeks to link drug treatment (pharmaco-) with the individual's genetic make-up (genomics). Pharmacogenomics holds many promises for improved treatment of a large variety of medical conditions, including immunosuppression for organ transplantation and autoimmune disease. Many of these promises...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
